1-Methylhydantoin-2-Imide is an innovative skin-brightening active ingredient designed to target pigmentation concerns. By inhibiting tyrosinase activity, it effectively regulates melanin synthesis, helping to reduce the appearance of dark spots and uneven skin tone. This makes it a valuable component in formulations aimed at achieving a clearer, brighter, and more balanced complexion.
Presented as a white to off-white powder, this ingredient is soluble in water, offering excellent compatibility with a wide range of cosmetic and skincare formulations including serums, lotions, and creams. With a flexible recommended dosage of 0.05–5.0%, it provides formulating versatility while ensuring strong efficacy.
1-Methylhydantoin-2-Imide — ZLEY®MHI
| INCI: | 1-Methylhydantoin-2-Imide |
| Properties: | Inhibits the production of enzyme tyrosinase. |
| Appearance: | White or off-white powder |
| Recommended dosage: | 0.05-5.0% |
| Solubility: | Soluble in water |
IF YOU WANT SAMPLES
Please fill in the information
ZLEY®MHI at a glance
ZLEY®MHI is supplied for brightening formulation development. Inhibits the production of enzyme tyrosinase.
- INCI
- 1-Methylhydantoin-2-Imide
- CAS
- Not publicly specified — confirm against the current SDS/TDS
- Content / purity
- Grade-specific; confirm the current TDS specification and batch COA
- Appearance
- White or off-white powder
- Recommended dosage
- 0.05-5.0%
- Solubility
- Soluble in water
Formulation and purchasing details View 10 additional specifications
- Addition phase
- Water phase or a validated aqueous pre-dispersion route; verify the current TDS order of addition
- Processing temperature
- Not publicly specified — confirm grade-specific processing limits in the current TDS
- pH
- Not publicly specified — confirm supplied-grade and finished-formula requirements
- Stability
- Validate compatibility, accelerated/real-time stability and final packaging in the finished formulation
- Storage
- Follow the current SDS/TDS and keep the material sealed under the stated storage conditions
- Shelf life
- Confirm against the current TDS and supplied batch documentation
- Applications
- BRIGHTENING formulations; confirm finished-product fit and target-market requirements
- Packaging
- Pack size is grade/order specific; confirm on the current quotation and specification
- MOQ
- Available on request; confirm grade, pack size, lead time and destination with ZLEY sales
- TDS / SDS / COA
- TDS on request; SDS on request; Batch-specific COA available on request
Values marked for confirmation are intentionally not estimated. Request the current grade-specific TDS/SDS and batch COA before scale-up or purchase.
Technical documents
Product FAQ
What is ZLEY®MHI?
ZLEY®MHI is supplied for brightening formulation development. Inhibits the production of enzyme tyrosinase. The declared INCI is: 1-Methylhydantoin-2-Imide.
What is the recommended use level for ZLEY®MHI?
The published or currently recorded use level is 0.05-5.0%. Final use level must be checked against the current TDS, the complete formula, target-market rules and finished-product testing.
How should ZLEY®MHI be incorporated?
Solubility: Soluble in water. Addition phase: Water phase or a validated aqueous pre-dispersion route; verify the current TDS order of addition. Processing temperature: Not publicly specified — confirm grade-specific processing limits in the current TDS.
Which technical and purchasing documents are available?
Request the current TDS; request the current SDS; request the batch-specific COA. Packaging and MOQ are order-specific and should be confirmed with ZLEY sales before purchase.
Technical review owner: ZLEY Group Technical Team Source review date: